Metabolic and Cardiovascular Dynamics in Liver Transplant Recipients
Summary
Liver transplantation has transformed the prognosis of end‐stage liver disease, yet long‐term outcomes are shaped increasingly by metabolic and cardiovascular factors rather than graft failure alone. Recipients frequently develop weight gain, insulin resistance, dyslipidaemia and hypertension under the influence of immunosuppressive regimens, lifestyle changes and the metabolic legacy of the pre‐transplant liver disease. Non-alcoholic steatohepatitis (NASH) as an indication for transplantation heralds a particularly high burden of post-transplant metabolic dysfunction. The convergence of these disturbances into metabolic syndrome amplifies cardiovascular risk, which now ranks among the leading causes of graft loss and mortality beyond the first year. Multidisciplinary management—encompassing tailored immunosuppression, dietary optimisation, exercise prescription and vigilant cardiovascular screening—is central to improving survival and quality of life in this expanding patient group.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Metabolic and Cardiovascular Dynamics in Liver Transplant Recipients publication trend
The graph below shows the total number of articles in metabolic and cardiovascular dynamics in liver transplant recipients across all publications each year (not limited to Nature Index journals).
Technical terms
Metabolic syndrome: A cluster of conditions including central obesity, hyperglycaemia, dyslipidaemia and hypertension that raise cardiovascular risk.
Non-alcoholic steatohepatitis (NASH): A form of fatty liver disease characterised by inflammation and hepatocellular injury in the absence of significant alcohol intake.
Dyslipidaemia: An abnormal concentration of lipids in the blood, often manifesting as elevated cholesterol or triglycerides.
Immunosuppressive therapy: Pharmacological agents, such as calcineurin inhibitors or corticosteroids, used to prevent graft rejection but associated with metabolic side effects.
Insulin resistance: A state in which target tissues respond inadequately to normal levels of insulin, promoting hyperglycaemia and type 2 diabetes.
References
- Nutritional Intake after Liver Transplant: Systematic Review and Meta-Analysis. Nutrients (2023).
- Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome after Liver Transplant. International Journal of Molecular Sciences (2016).
- Metabolic Disorders in Liver Transplant Recipients: The State of the Art. Journal of Clinical Medicine (2024).
- Cardiovascular and Metabolic Consequences of Liver Transplantation: A Review. Medicina (2019).
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.